Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

CORONA PATHOLOGY — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report (No Activity)

CORONA PATHOLOGY

via BECKER & POLIAKOFF, P.A.

2nd Quarter (Apr 1 - June 30) · 2020Posted Jul 20, 2020Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: CORONA PATHOLOGY
Description: Pathology laboratory
Location: California · United States of America

Registrant

Firm: BECKER & POLIAKOFF, P.A.
Description: Law firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.